Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.
Zuber J, Le Quintrec M, Krid S, Bertoye C, Gueutin V, Lahoche A, Heyne N, Ardissino G, Chatelet V, Noël LH, Hourmant M, Niaudet P, Frémeaux-Bacchi V, Rondeau E, Legendre C, Loirat C; French Study Group for Atypical HUS. Zuber J, et al. Among authors: heyne n. Am J Transplant. 2012 Dec;12(12):3337-54. doi: 10.1111/j.1600-6143.2012.04252.x. Epub 2012 Sep 7. Am J Transplant. 2012. PMID: 22958221 Free article.
Standardized, risk-adapted induction therapy in kidney transplantation.
Eisinger F, Mühlbacher T, Na A, Althaus K, Nadalin S, Birkenfeld AL, Heyne N, Guthoff M. Eisinger F, et al. Among authors: heyne n. J Nephrol. 2023 Sep;36(7):2133-2138. doi: 10.1007/s40620-023-01746-1. Epub 2023 Sep 9. J Nephrol. 2023. PMID: 37688753 Free PMC article.
Uterine allograft removal by total laparoscopic hysterectomy after successful cesarean delivery in a living-donor uterus recipient with uterovaginal agenesis (MRKHS).
Brucker SY, Krämer B, Abele H, Henes M, Hoopmann M, Schöller D, Königsrainer A, Bösmüller H, Nikolaou K, Krumm P, Rosenberger P, Heim E, Amend B, Rausch S, Althaus K, Bakchoul T, Guthoff M, Heyne N, Nadalin S, Rall KK. Brucker SY, et al. Among authors: heyne n. Arch Gynecol Obstet. 2023 Mar;307(3):827-840. doi: 10.1007/s00404-022-06796-7. Epub 2022 Nov 7. Arch Gynecol Obstet. 2023. PMID: 36342536 Free PMC article.
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon SS, Kavanagh D, Haller H; 311 Study Group. Rondeau E, et al. Among authors: heyne n. Kidney Int. 2020 Jun;97(6):1287-1296. doi: 10.1016/j.kint.2020.01.035. Epub 2020 Mar 6. Kidney Int. 2020. PMID: 32299680 Free article. Clinical Trial.
104 results